Publications

BibTex format

@article{Brady:2001,
author = {Brady, F and Luthra, SK and Brown, GD and Osman, S and Aboagye, E and Saleem, A and Price, PM},
journal = {Curr Pharm Des},
pages = {1863--1892},
title = {Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET},
url = {http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11772355},
volume = {7},
year = {2001}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Positron Emission Tomography (PET) has the potential to improve efficacy of established and novel cancer therapies and to assist more rapid and rational progression of promising novel therapies into the clinic. This is due to PET's unrivalled sensitivity and ability to monitor the pharmacokinetics and pharmacodynamics of drugs and biochemicals radiolabelled with short -lived positron emitting radioisotopes. PET is a multidisciplinary science which employs chemists, biologists, mathematical modellers, pharmacologists as well as clinicians. Clinical research questions in oncology determine the methodological challenges faced by these other disciplines. Within this context we focus on the developments of the radiolabelled compounds that have underpinned the clinical work in oncology for monitoring tumour and normal tissue pharmacokinetics, assessment of tumour response, cell proliferation, gene expression, hypoxia, multidrug resistance and status of receptors on tumours.
AU  - Brady,F
AU  - Luthra,SK
AU  - Brown,GD
AU  - Osman,S
AU  - Aboagye,E
AU  - Saleem,A
AU  - Price,PM
EP  - 1892
PY  - 2001///
SP  - 1863
TI  - Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET
T2  - Curr Pharm Des
UR  - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11772355
VL  - 7
ER  -

Download

ProfessorPatriciaPrice

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)